Literature DB >> 30608869

Use of Prasugrel and Ticagrelor in Stable Ischemic Heart Disease After Percutaneous Coronary Intervention, 2009-2016.

Elias J Dayoub1,2,3, Ashwin S Nathan2,3,4, Sameed Ahmed M Khatana2,3,4, Matthew Seigerman4, Sony Tuteja5, Taisei Kobayashi1,2,4, Daniel M Kolansky4, Peter W Groeneveld1,2,3, Jay Giri1,2,3,4.   

Abstract

Entities:  

Keywords:  acute coronary syndrome; clopidogrel; heart diseases; percutaneous coronary intervention; ticagrelor

Mesh：

Substances：

Year:  2019        PMID： 30608869      PMCID： PMC6485954          DOI： 10.1161/CIRCINTERVENTIONS.118.007434

Source DB:  PubMed          Journal:  Circ Cardiovasc Interv        ISSN： 1941-7640            Impact factor:   6.546


× No keyword cloud information.
  4 in total

1.  Potent P2Y12 Inhibitors in Low-Risk Patients: Is There a Medical Need?

Authors:  Johanne Silvain; Mathieu Kerneis; Gilles Montalescot
Journal:  J Am Coll Cardiol       Date:  2016-02-16       Impact factor: 24.094

2.  Trends in Platelet Adenosine Diphosphate P2Y12 Receptor Inhibitor Use and Adherence Among Antiplatelet-Naive Patients After Percutaneous Coronary Intervention, 2008-2016.

Authors:  Elias J Dayoub; Matthew Seigerman; Sony Tuteja; Taisei Kobayashi; Daniel M Kolansky; Jay Giri; Peter W Groeneveld
Journal:  JAMA Intern Med       Date:  2018-07-01       Impact factor: 21.873

Review 3.  2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines: An Update of the 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention, 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery, 2012 ACC/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease, 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction, 2014 AHA/ACC Guideline for the Management of Patients With Non-ST-Elevation Acute Coronary Syndromes, and 2014 ACC/AHA Guideline on Perioperative Cardiovascular Evaluation and Management of Patients Undergoing Noncardiac Surgery.

Authors:  Glenn N Levine; Eric R Bates; John A Bittl; Ralph G Brindis; Stephan D Fihn; Lee A Fleisher; Christopher B Granger; Richard A Lange; Michael J Mack; Laura Mauri; Roxana Mehran; Debabrata Mukherjee; L Kristin Newby; Patrick T O'Gara; Marc S Sabatine; Peter K Smith; Sidney C Smith
Journal:  Circulation       Date:  2016-03-29       Impact factor: 29.690

4.  Study of Two Dose Regimens of Ticagrelor Compared with Clopidogrel in Patients Undergoing Percutaneous Coronary Intervention for Stable Coronary Artery Disease (STEEL-PCI).

Authors:  Rachel C Orme; William A E Parker; Mark R Thomas; Heather M Judge; Kathleen Baster; Wael Sumaya; Kenneth P Morgan; Hannah C McMellon; James D Richardson; Ever D Grech; Nigel M Wheeldon; Ian R Hall; Javaid Iqbal; David Barmby; Julian P Gunn; Robert F Storey
Journal:  Circulation       Date:  2018-06-21       Impact factor: 29.690
  4 in total
  5 in total

1.  Identifying Racial, Ethnic, and Socioeconomic Inequities in the Use of Novel P2Y12 Inhibitors After Percutaneous Coronary Intervention.

Authors:  Ashwin S Nathan; Zhi Geng; Lauren A Eberly; Nwamaka D Eneanya; Elias J Dayoub; Sameed Ahmed M Khatana; Daniel M Kolansky; Taisei J Kobayashi; Sony Tuteja; Alexander C Fanaroff; Jay Giri; Peter W Groeneveld
Journal:  J Invasive Cardiol       Date:  2022-01-16       Impact factor: 1.711

2.  Acute and 1-Year Hospitalization Costs for Acute Myocardial Infarction Treated With Percutaneous Coronary Intervention: Results From the TRANSLATE-ACS Registry.

Authors:  Patricia A Cowper; J David Knight; Linda Davidson-Ray; Eric D Peterson; Tracy Y Wang; Daniel B Mark
Journal:  J Am Heart Assoc       Date:  2019-04-16       Impact factor: 5.501

3.  Tai Chi Improves Coronary Heart Disease Risk by Inactivating MAPK/ERK Pathway through Serum miR-126.

Authors:  Guangwei Zhang; Shuli Wang; Yan Gu; Ling Song; Shui Yu; Xiaoxing Feng
Journal:  Evid Based Complement Alternat Med       Date:  2020-04-25       Impact factor: 2.629

4.  A Japanese Dose of Prasugrel versus a Standard Dose of Clopidogrel in Patients with Acute Myocardial Infarction from the K-ACTIVE Registry.

Authors:  Hiroyoshi Mori; Takuya Mizukami; Atsuo Maeda; Kazuki Fukui; Yoshihiro Akashi; Junya Ako; Yuji Ikari; Toshiaki Ebina; Kouichi Tamura; Atsuo Namiki; Ichiro Michishita; Kazuo Kimura; Hiroshi Suzuki
Journal:  J Clin Med       Date:  2022-04-04       Impact factor: 4.241

5.  The 24-Form Tai Chi Improves Anxiety and Depression and Upregulates miR-17-92 in Coronary Heart Disease Patients After Percutaneous Coronary Intervention.

Authors:  Jia Liu; Ping Yu; Wei Lv; Xinxin Wang
Journal:  Front Physiol       Date:  2020-03-11       Impact factor: 4.566
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.